Resources

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

PATH’s Safe Water Project is exploring the potential for commercial enterprises to reach low-income populations with household water treatment and storage devices. This document describes the household water treatment and storage market and low-income user needs to guide current or potential manufacturers’ decisions about where it is most or least fruitful to try to increase end-user satisfaction.

Since 2009, PATH has been working with government family planning officials to engage stakeholders and apply evidence to develop a total market plan for family planning in light of funding shortfalls. This case study in Vietnam is intended to highlight lessons learned and recommendations for those considering similar initiatives in other settings. It is a sister document to the Nicaragua case study, Developing Total Market Strategies for Family Planning in Nicaragua.

This second annual policy report from the Global Health Technologies Coalition—a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for vaccines, diagnostics, drugs, microbicides, and other products that save lives in the developing world—outlines some of the steps that will help curb unnecessary deaths, extend lives, and secure healthier futures. Serving as a guide for policymakers, the report documents promising policy actions taken over the past year in the areas of US investments in global health and international development, regulatory pathways to ensure the safety and efficacy of health tools, and incentives and innovative financing mechanisms to spur global health product development. This report offers recommendations for how US policymakers can continue to have a lead in improving health worldwide.

This white paper highlights the value of a comprehensive approach to procurement capacity development in developing countries.